science-product-detail
IVM for expected high responders: balancing the effectiveness and safety: In Reply
B.W. Mol L.N. Vuong
Abstract
KEYWORDS:
Download
Similar articles
-
Review Large randomized controlled trials in infertility
[ Rui Wang, M.D., Ph.D.a, Zi-Jiang Chen, M.D., Ph.D.b,c,d, Lan N. Vuong, M.D., Ph.D.e, Richard S. Legro, M.D.f, Ben W. Mol, M.D., Ph.D.a and Jack Wilkinson, Ph.D.g ]
As the first paper in this series of Views and Reviews on randomized controlled trials (RCTs), we aim to provide the b...
-
Review Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35–42 years with a body weight ≥50 kg: a randomized controlled trial
[ N.L. Vuong1,2,*, D.T. Pham2, H.T. Phung2, H.N. Giang2, G.B. Huynh2, T.T.L. Nguyen2, and M.T. Ho2,3 ]
STUDY QUESTION
Is corifollitropin alfa 150 μg equivalent to follitropin beta 300 IU/day for controlled ovarian... -
Review Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study
[ Duy L Nguyen 1, Nghia A Nguyen 1 2, Toan D Pham 1, Minh H N Nguyen 1, Lan N Vuong 3 4 ]
Purpose: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte...
-
Review POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research
[ Sandro C.Estevesab, HakanYaralic, Lan N.Vuongdef, AlessandroConfortig, PeterHumaidanbh, CarloAlviggig ]
The Patient-Oriented Strategies Enc...
-
Review Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
[ Sandro C Esteves1, Hakan Yarali2,3, Lan N Vuong4,5,6, José F Carvalho7, İrem Y Özbek2, Mehtap Polat2, Ho L Le4,5, Toan D Pham4,5, Tuong M Ho4,5 ]
STUDY QUESTION